Is Elevance Health (ELV) Entering a Major Earnings Recovery?

Greenskeeper Asset Management's Q2 2026 scorecard highlighted Elevance Health (ELV) as a strong contributor, with its stock gaining 32.1% in the quarter. The firm expects profitability to improve for ELV, anticipating 2026 to be the bottom for operating margins before an earnings recovery in 2027 driven by stabilized cost trends and favorable reimbursement updates. Despite this positive outlook, the article notes that ELV is not among the 40 most popular stocks among hedge funds, suggesting other AI stocks might offer greater upside.